Axsome Therapeutics (AXSM) Research & Development (2015 - 2026)
Axsome Therapeutics (AXSM) reported Research & Development of $46.23 million for Q2 2026, down 6.7% from $49.54 million a year earlier and down 12.2% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Research & Development (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Axsome Therapeutics' Research & Development came in at $187.86 million, down 3.5% year-over-year; for FY2025, it came in at $183.28 million, down 2.0% from FY2024.
- Research & Development has a five-year compound annual growth rate of 21.1% (FY2020 to FY2025).
- By year, Research & Development came in at $187.08 million in FY2024 (+91.0%), $97.94 million in FY2023 (+69.0%), $57.95 million in FY2022 (-0.2%) and $58.06 million in FY2021 (-17.3%).
- Five-year quarterly Research & Development spans a low of $12.59 million in Q1 2022 and a high of $55.01 million in Q4 2024.
- Year over year, Research & Development gained in four of the last eight quarters, with growth averaging 18.2%.
- The high point for year-over-year Research & Development in five years was Q2 2024 (growth of 142.2%); the low point was Q1 2022 (a decline of 24.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $52.68 million (Q1 2026), $48.79 million (Q4 2025) and $40.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Axsome Therapeutics | 10.14 Bn | 8.87 Bn | 204.81 Mn | 46.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.23 Mn |
| Mar 31, 2026 | 52.68 Mn |
| Dec 31, 2025 | 48.79 Mn |
| Sep 30, 2025 | 40.16 Mn |
| Jun 30, 2025 | 49.54 Mn |
| Mar 31, 2025 | 44.79 Mn |
| Dec 31, 2024 | 55.01 Mn |
| Sep 30, 2024 | 45.39 Mn |
| Jun 30, 2024 | 49.85 Mn |
| Mar 31, 2024 | 36.83 Mn |
| Dec 31, 2023 | 30.80 Mn |
| Sep 30, 2023 | 28.77 Mn |
| Jun 30, 2023 | 20.58 Mn |
| Mar 31, 2023 | 17.79 Mn |
| Dec 31, 2022 | 14.69 Mn |
| Sep 30, 2022 | 14.88 Mn |
| Jun 30, 2022 | 15.79 Mn |
| Mar 31, 2022 | 12.59 Mn |
| Dec 31, 2021 | 13.78 Mn |
| Sep 30, 2021 | 13.18 Mn |
API Access
Axsome Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();